Auro Laboratories Limited has submitted the Audited Financial Results for the quarter and year ended March 31 2025.

Management Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.4%Reaction day

₹249.00

prior close

₹247.25

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+4.3% vs market

Pharmaceuticals peers, median of 147sector-0.1%+4.5% vs sector

On the reaction day the stock moved 4.3 pts more than Nifty Microcap 250 and 4.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.9

10m

-1.9

15m

-3.8

30m

+1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.4+0.1+4.3-0.1+4.5

Next day

+6.8-0.2+7.0-0.3+7.1

+14.4+0.3+14.1-0.3+14.7

+15.3+0.9+14.4+0.0+15.3

+14.8+0.8+14.1+0.0+14.8

+15.7+2.2+13.5+0.6+15.1

+14.0+3.4+10.6+1.4+12.6

15d

+3.9-0.8+4.7-3.0+7.0

+5.0+2.9+2.1+0.2+4.8

+7.1+0.8+6.2-0.5+7.6

-11.3+0.0-11.3-3.2-8.0

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Auro Laboratories Limited has reported its audited financial results for the quarter and year ended March 31, 2025. Full-year revenue from operations fell sharply to ₹1,939.84 lakhs from ₹5,363.52 lakhs in FY24, while profit after tax dropped to ₹183.88 lakhs from ₹779.21 lakhs. Q4 FY25 revenue was ₹740 lakhs versus ₹1,206.29 lakhs in Q4 FY24, with Q4 profit at ₹39.42 lakhs (down from ₹232.05 lakhs). The Board approved the appointment of Mr. Kuntal Pancholi as the new Chief Financial Officer and Key Managerial Personnel effective May 30, 2025, and M/s. Pokharna and Associates as Internal Auditors for FY 2025-26. Statutory Auditors Kothari Jain & Associates issued an unmodified (clean) opinion on the results.

Likely market impact

The sharp year-on-year decline in both revenue and profitability is a red flag for shareholders, although ongoing capital expenditure (capital work-in-progress nearly doubled) suggests management is investing for future capacity. The mid-year CFO changeover, combined with rising borrowings (from ₹1,838 lakhs to ₹3,309 lakhs), points to a period of transition that investors should watch closely.